Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 13 October, 2009 and appeared in  Issue 490Cardiovascular HealthWomen's Health and OB-GYN

Lower Cut-Offs Needed in Screening for Gestational Diabetes

Some women who test negative for gestational diabetes on glucose challenge and glucose tolerance tests are still at significant risk of developing Type 2 diabetes and hypertension 15 years later. 
Advertisement

Dr. Wing-hung Tam and colleagues at the Chinese University of Hong Kong followed 149 women (45 positive for gestational diabetes) for 15 years after delivery. The women had originally been enrolled in a study on the optimal screening and diagnosis of gestational diabetes during pregnancy.

During the second trimester, each subject had undergone a 1-hour glucose challenge test, 75-gram oral glucose tolerance test, and a post prandial glucose plasma test.

All the glycemic indices were predictive of abnormal glucose tolerance and diabetes on 8- and 15-year follow up, Dr. Tam said.

Dr. Tam said the study had shown that a glucose challenge test result of 139mg/dL (7.7 mmol/L) was the optimal cutoff for predicting the long-term development of diabetes.

Currently, a glucose challenge test result of 140mg/dL (7.8 mmol/L) or higher is considered positive for gestational diabetes -- but in this study, a result of 138mg/dL (7.7 mmol/L) or higher was association with a 16-fold higher risk of diabetes at both 8 and 15 years postpartum compared to results below 138mg/dL (7.7 mmol/L).

"The optimal cutoff in our 2-hour oral glucose tolerance test was 129mg/dL (7.2 mmol/L), which is also lower than current criteria," Dr. Tam added. "Those with a 2-hour glucose level of 129mg/dL (7.2mmol/L) or higher had a 6-fold increase in the risk of developing Type 2 diabetes at both 8 and 15 years."

Dr. Tam stated that, "We have shown that there is a certain optimal glycemic threshold in the oral glucose tolerance test and glucose challenge test from which we can predict long term maternal cardiometabolic risk outcome."

"Our group is now following up the cohort from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study," Dr. Tam said, adding that he anticipates new guidelines on screening for gestational diabetes to be released before the year end.

Reported at the 11th Diabetes and Cardiovascular Risk Factors - East Meets West Symposium, Oct . 2009.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 October, 2009 and appeared in  Issue 490Cardiovascular HealthWomen's Health and OB-GYN

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

2012 Most Popular Articles:

ADA/EASD Issue New Hyperglycemia Management Guidelines
Posted April 26, 2012
Type 2 More Dangerous in Children
Posted May 03, 2012
It’s the Variety of Fruit-and-Veggie That Lower Diabetes Risk
Posted May 03, 2012
Questioning Carbohydrate Restriction in Diabetes Management
Posted May 18, 2012
Ultra-Long-Acting Insulin Degludec, Two New Studies
Posted April 26, 2012
Eating Low Glycemic Index Foods at Breakfast Can Control Blood Sugar throughout the Day
Posted April 18, 2012
Metformin May Treat a Leading Cause of Blindness
Posted May 10, 2012
A Candy Treatment that Fights Diabetes and May Replace TZD's?
Posted May 10, 2012
Metformin May Not Be the Golden Pill After All for Treating Type 2 Diabetes
Posted April 18, 2012
Doubts Over Long Term Effectiveness of Group Education for Diabetes Patients
Posted May 03, 2012

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:



Search Articles On Diabetes In Control